<?xml version="1.0" encoding="UTF-8"?>
<html><body class="spl" id="spl">
<div class="DocumentTitle"><p class="DocumentTitle"><strong>PROPARACAINE HYDROCHLORIDE- proparacaine hydrochloride solution/ drops </strong><br>Akorn, Inc.<br></p></div>
<h1>Proparacaine Hydrochloride Ophthalmic Solution USP, 0.5% Sterile</h1>
<div class="Contents">
<div class="Section" data-sectionCode="48780-1">
<a name="dcl-dpl"></a><a name="section-1"></a><p></p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="e0"></a><a name="section-1"></a><p></p>
<p class="First"><span class="Bold">Sterile</span></p>
<p><span class="Bold">Rx only</span></p>
</div>
<div class="Section" data-sectionCode="34089-3">
<a name="s0"></a><a name="section-2"></a><p></p>
<h1>DESCRIPTION</h1>
<p class="First">Proparacaine Hydrochloride Ophthalmic Solution USP, 0.5% is a local anesthetic for ophthalmic instillation. Each mL of sterile, aqueous solution contains: Active: Proparacaine Hydrochloride 5 mg (0.5%). Preservative: Benzalkonium Chloride 0.1 mg (0.01%). Inactives: Glycerin as a stabilizer, Hydrochloric Acid and/or Sodium Hydroxide may be added to adjust pH (3.5 to 6.0), and Water for Injection USP.</p>
<p>Proparacaine hydrochloride is designed chemically as 2-(Diethylamino)ethyl 3-amino-4-propoxybenzoate monohydrochloride. The active ingredient is represented by the structural formula:</p>
<p><img alt="Chemical Structure" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=37cde651-2549-43f3-97b9-cdc442a0aa7a&amp;name=pro0c-0002-01.jpg"></p>
</div>
<div class="Section" data-sectionCode="34090-1">
<a name="s1"></a><a name="section-3"></a><p></p>
<h1>CLINICAL PHARMACOLOGY</h1>
<p class="First">Proparacaine Hydrochloride Ophthalmic Solution is a rapid acting local anesthetic suitable for ophthalmic use. With a single drop, the onset of anesthesia begins within 30 seconds and persists for 15 minutes or longer.</p>
<p>The main site of anesthetic action is the nerve cell membrane where proparacaine interferes with the large transient increase in the membrane permeability to sodium ions that is normally produced by a slight depolarization of the membrane. As the anesthetic action progressively develops in a nerve, the threshold for electrical stimulation gradually increases and the safety factor for conduction decreases; when this action is sufficiently well developed, block of conduction is produced.</p>
<p>The exact mechanism whereby proparacaine and other local anesthetics influence the permeability of the cell membrane is unknown; however, several studies indicate that local anesthetics may limit sodium ion permeability by closing the pores through which the ions migrate in the lipid layer of the nerve cell membrane. This limitation prevents the fundamental change necessary for the generation of the action potential.</p>
</div>
<div class="Section" data-sectionCode="34067-9">
<a name="s2"></a><a name="section-4"></a><p></p>
<h1>INDICATIONS AND USAGE</h1>
<p class="First">Proparacaine Hydrochloride Ophthalmic Solution is indicated for topical anesthesia in ophthalmic practice. Representative ophthalmic procedures in which the preparation provides good local anesthesia include measurement of intraocular pressure (tonometry), removal of foreign bodies and sutures from the cornea, conjunctival scraping in diagnosis and gonioscopic examination; it is also indicated for use as a topical anesthetic prior to surgical operations such as <span class="product-label-link" type="condition" conceptid="375545" conceptname="Cataract">cataract</span> extraction.</p>
</div>
<div class="Section" data-sectionCode="34070-3">
<a name="s3"></a><a name="section-5"></a><p></p>
<h1>CONTRAINDICATIONS</h1>
<p class="First">This preparation is contraindicated in patients with known <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">hypersensitivity</span> to any component of the solution.</p>
</div>
<div class="Section" data-sectionCode="34071-1">
<a name="s4"></a><a name="section-6"></a><p></p>
<h1>WARNINGS</h1>
<p class="First">NOT FOR INJECTION. FOR TOPICAL OPHTHALMIC USE ONLY.</p>
<p>Prolonged use of a topical ocular anesthetic may produce permanent corneal opacification with accompanying <span class="product-label-link" type="condition" conceptid="377551" conceptname="Blind hypertensive eye">loss of vision</span>.</p>
</div>
<div class="Section" data-sectionCode="42232-9">
<a name="s5"></a><a name="section-7"></a><p></p>
<h1>PRECAUTIONS</h1>
<div class="Section" data-sectionCode="34072-9">
<a name="s6"></a><a name="section-7.1"></a><p></p>
<h2>General</h2>
<p class="First">Proparacaine should be used cautiously and sparingly in patients with known allergies, cardiac disease, or <span class="product-label-link" type="condition" conceptid="4142479" conceptname="Hyperthyroidism">hyperthyroidism</span>. The long-term toxicity of proparacaine is unknown; prolonged use may possibly delay <span class="product-label-link" type="condition" conceptid="4029919" conceptname="Wound">wound</span> healing. Although exceedingly rare with ophthalmic application of local anesthetics, it should be borne in mind that systemic toxicity (manifested by central nervous system stimulation followed by <span class="product-label-link" type="condition" conceptid="438727" conceptname="Atypical depressive disorder">depression</span>) may occur.</p>
<p>Protection of the eye from irritating chemicals, foreign bodies and rubbing during the period of anesthesia is very important. Tonometers soaked in sterilizing or detergent solutions should be thoroughly rinsed with sterile distilled water prior to use. Patients should be advised to avoid touching the eye until the anesthesia has worn off. Do not touch dropper tip to any surface as this may contaminate the solution.</p>
</div>
<div class="Section" data-sectionCode="34083-6">
<a name="s7"></a><a name="section-7.2"></a><p></p>
<h2>Carcinogenesis, Mutagenesis, Impairment of Fertility</h2>
<p class="First">Long-term studies in animals have not been performed to evaluate carcinogenic potential, mutagenicity, or possible impairment of fertility in males or females.</p>
</div>
<div class="Section" data-sectionCode="42228-7">
<a name="s8"></a><a name="section-7.3"></a><p></p>
<h2>Pregnancy</h2>
<div class="Section" data-sectionCode="34077-8">
<a name="s9"></a><a name="section-7.3.1"></a><p></p>
<h3>Teratogenic Effects</h3>
<div class="Section" data-sectionCode="42229-5">
<a name="s10"></a><a name="section-7.3.1.1"></a><p></p>
<h4>Category C</h4>
<p class="First">Animal reproduction studies have not been conducted with Proparacaine Hydrochloride Ophthalmic Solution. It is also not known whether proparacaine hydrochloride can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. Proparacaine hydrochloride should be administered to a pregnant woman only if clearly needed.</p>
</div>
</div>
</div>
<div class="Section" data-sectionCode="34080-2">
<a name="s11"></a><a name="section-7.4"></a><p></p>
<h2>Nursing Mothers</h2>
<p class="First">It is not known whether this drug is excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when proparacaine hydrochloride is administered to a nursing woman.</p>
</div>
<div class="Section" data-sectionCode="34081-0">
<a name="s12"></a><a name="section-7.5"></a><p></p>
<h2>Pediatric Use</h2>
<p class="First">Controlled clinical studies have not been performed with Proparacaine Hydrochloride Ophthalmic Solution to establish safety and effectiveness in pediatric patients; however, the literature cites the use of proparacaine hydrochloride as a topical ophthalmic anesthetic agent in pediatric patients.</p>
</div>
</div>
<div class="Section" data-sectionCode="34084-4">
<a name="s13"></a><a name="section-8"></a><p></p>
<h1>ADVERSE REACTIONS</h1>
<p class="First">Pupillary dilatation or cycloplegic effects have rarely been observed with proparacaine hydrochloride. The drug appears to be safe for use in patients sensitive to other local anesthetics, but local or systemic sensitivity occasionally occurs. Instillation of proparacaine in the eye at recommended concentration and dosage usually produces little or no initial irritation, <span class="product-label-link" type="condition" conceptid="4329041" conceptname="Pain">stinging</span>, burning, <span class="product-label-link" type="condition" conceptid="377283" conceptname="Conjunctival hyperemia">conjunctival redness</span>, <span class="product-label-link" type="condition" conceptid="435553" conceptname="Epiphora">lacrimation</span> or increased winking. However, some local irritation and <span class="product-label-link" type="condition" conceptid="4329041" conceptname="Pain">stinging</span> may occur several hours after the instillation.</p>
<p>Rarely, a severe, immediate-type, apparently hyperallergic corneal reaction may occur which includes acute, intense and diffuse epithelial <span class="product-label-link" type="condition" conceptid="374035" conceptname="Keratitis">keratitis</span>; a gray, ground-glass appearance; <span class="product-label-link" type="condition" conceptid="4032013" conceptname="Desquamation">sloughing</span> of large areas of necrotic epithelium; corneal filaments and, sometimes, <span class="product-label-link" type="condition" conceptid="4274964" conceptname="Iritis">iritis</span> with <span class="product-label-link" type="condition" conceptid="374035" conceptname="Keratitis">descemetitis</span>.</p>
<p><span class="product-label-link" type="condition" conceptid="134438" conceptname="Contact dermatitis">Allergic contact dermatitis</span> with drying and fissuring of the fingertips has been reported.</p>
<p>Softening and erosion of the corneal epithelium and <span class="product-label-link" type="condition" conceptid="377283" conceptname="Conjunctival hyperemia">conjunctival congestion</span> and <span class="product-label-link" type="condition" conceptid="437312" conceptname="Bleeding">hemorrhage</span> have been reported.</p>
</div>
<div class="Section" data-sectionCode="34068-7">
<a name="s14"></a><a name="section-9"></a><p></p>
<h1>DOSAGE AND ADMINISTRATION</h1>
<p class="First"><span class="Italics">Deep anesthesia as in <span class="product-label-link" type="condition" conceptid="375545" conceptname="Cataract">cataract</span> extraction:</span></p>
<dl>
<dt></dt>
<dd>Instill 1 drop to the eye every 5 to 10 minutes for 5 to 7 doses.</dd>
</dl>
<p><span class="Italics">Removal of sutures:</span></p>
<dl>
<dt></dt>
<dd>Instill 1 or 2 drops to the eye 2 or 3 minutes before removal of stitches.</dd>
</dl>
<p><span class="Italics">Removal of foreign bodies:</span></p>
<dl>
<dt></dt>
<dd>Instill 1 or 2 drops to the eye prior to operating.</dd>
</dl>
<p><span class="Italics">Tonometry:</span></p>
<dl>
<dt></dt>
<dd>Instill 1 or 2 drops to the eye immediately before measurement.</dd>
</dl>
</div>
<div class="Section" data-sectionCode="34069-5">
<a name="s15"></a><a name="section-10"></a><p></p>
<h1>HOW SUPPLIED</h1>
<p class="First">Proparacaine Hydrochloride Ophthalmic Solution USP, 0.5% is supplied as a sterile solution in 15 mL plastic dropper bottles — NDC 17478-263-12</p>
<div class="Section" data-sectionCode="44425-7">
<a name="s16"></a><a name="section-10.1"></a><p></p>
<h2>STORAGE</h2>
<p class="First">Refrigerate at 2° to 8°C (36° to 46°F). Keep bottle tightly closed. Store in carton until empty to protect from light. If solution shows more than a <span class="product-label-link" type="condition" conceptid="135360" conceptname="Syncope">faint</span> yellow color, it should not be used.</p>
<p><span class="Bold">WARNING — KEEP THIS AND ALL DRUGS OUT OF THE REACH OF CHILDREN.</span></p>
</div>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="s17"></a><a name="section-11"></a><p></p>
<p class="First"><span class="Bold">Akorn</span><br>Manufactured by: Akorn, Inc.<br>
Lake Forest, IL 60045</p>
<p>PH00N<br>Rev. 09/08</p>
</div>
<div class="Section" data-sectionCode="51945-4">
<a name="s18"></a><a name="section-12"></a><p></p>
<p class="First">Principal Display Panel Text for Container Label:
</p>
<p>NDC 17478-263-12
</p>
<p>Proparacaine
</p>
<p>Hydrochloride
</p>
<p>Ophthalmic
</p>
<p>Solution, USP
</p>
<p>0.5%
</p>
<p>15mL
</p>
<p>Sterile
</p>
<p>Rx only    Akorn Logo
</p>
<div class="Figure">
<a name="f02"></a><img alt="Principal Display Panel Text for Container Label
" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=37cde651-2549-43f3-97b9-cdc442a0aa7a&amp;name=pro0c-0002-02.jpg">
</div>
</div>
<div class="Section" data-sectionCode="51945-4">
<a name="s19"></a><a name="section-13"></a><p></p>
<p class="First">Principal Display Panel Text for Carton Label:
</p>
<p>NDC 17478-263-12
</p>
<p>Proparacaine
</p>
<p>Hydrochloride
</p>
<p>Ophthalmic
</p>
<p>Solution, USP
</p>
<p>0.5%
</p>
<p>FOR TOPICAL
</p>
<p>OPHTHALMIC USE ONLY
</p>
<p>NOT FOR INJECTION
</p>
<p>15mL
</p>
<p>Sterile
</p>
<p>Rx only    Akorn Logo
</p>
<div class="Figure">
<a name="f03"></a><img alt="Principal Display Panel Text for Carton Label
" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=37cde651-2549-43f3-97b9-cdc442a0aa7a&amp;name=pro0c-0002-03.jpg">
</div>
</div>
</div>
<div class="DataElementsTables">
<table class="contentTablePetite" cellSpacing="0" cellPadding="3" width="100%"><tbody>
<tr><td class="contentTableTitle">
<strong>PROPARACAINE HYDROCHLORIDE 		
					</strong><br><span class="contentTableReg">proparacaine hydrochloride solution/ drops</span>
</td></tr>
<tr><td><table width="100%" cellpadding="5" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Information</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Product Type</td>
<td class="formItem">HUMAN PRESCRIPTION DRUG LABEL</td>
<td class="formLabel">Item Code (Source)</td>
<td class="formItem">NDC:17478-263</td>
</tr>
<tr class="formTableRow">
<td width="30%" class="formLabel">Route of Administration</td>
<td class="formItem">OPHTHALMIC</td>
<td width="30%" class="formLabel">DEA Schedule</td>
<td class="formItem">    
							</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="3" class="formHeadingTitle">Active Ingredient/Active Moiety</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Basis of Strength</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">
<strong>Proparacaine Hydrochloride</strong> (Proparacaine) </td>
<td class="formItem">Proparacaine Hydrochloride</td>
<td class="formItem">5 mg  in 1 mL</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="2" class="formHeadingTitle">Inactive Ingredients</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>Glycerin</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>Hydrochloric Acid</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>Sodium Hydroxide</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>Water</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>Benzalkonium Chloride</strong></td>
<td class="formItem"> </td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="5" class="formHeadingTitle">Packaging</td></tr>
<tr>
<th scope="col" width="1" class="formTitle">#</th>
<th scope="col" class="formTitle">Item Code</th>
<th scope="col" class="formTitle">Package Description</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem">NDC:17478-263-12</td>
<td class="formItem">1  in 1 CARTON</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem"></td>
<td class="formItem">15 mL in 1 BOTTLE, DROPPER</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td class="normalizer"><table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Marketing Information</span></td></tr>
<tr>
<th scope="col" class="formTitle">Marketing Category</th>
<th scope="col" class="formTitle">Application Number or Monograph Citation</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">ANDA</td>
<td class="formItem">ANDA040277</td>
<td class="formItem">03/16/2000</td>
<td class="formItem"></td>
</tr>
</table></td></tr>
</tbody></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite"><tr><td colspan="4" class="formHeadingReg">
<span class="formHeadingTitle">Labeler - </span>Akorn, Inc.
							(062649876)
						</td></tr></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Establishment</span></td></tr>
<tr>
<th scope="col" class="formTitle">Name</th>
<th scope="col" class="formTitle">Address</th>
<th scope="col" class="formTitle">ID/FEI</th>
<th scope="col" class="formTitle">Business Operations</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">Akorn, Inc.</td>
<td class="formItem"></td>
<td class="formItem">155135783</td>
<td class="formItem">MANUFACTURE, REPACK, ANALYSIS, LABEL, PACK, RELABEL, STERILIZE</td>
</tr>
</table>
</div>
<p><div class="EffectiveDate">Revised: 12/2011<div class="DocumentMetadata">
<div>
<a href="javascript:toggleMixin();">Document Id: </a>61f6f83c-a75f-4eb2-a4f1-e274bbbff738</div>
<div>Set id: 37cde651-2549-43f3-97b9-cdc442a0aa7a</div>
<div>Version: 3</div>
<div>Effective Time: 20111221</div>
</div>
</div> <div class="DistributorName">Akorn, Inc.</div></p>
</body></html>
